The only extended-release bupropion with more than 15 years of experience in MDD and more than 10 years of experience in SAD.
15years in MDD
More than 15 years of clinical experience in
major depressive disorder (MDD) and more
than 10 years of clinical experience in seasonal
affective disorder (SAD).1-3
Learn more about the patient experience with WELLBUTRIN XL and access valuable resources and support.
Learn what makes branded WELLBUTRIN XL different from generic formulations of bupropion HCl.
With the Copay Savings Program, eligible* commercially insured patients pay as little as $5 at their local pharmacy for each 30-day supply.
*Maximum benefits apply. For eligible commercially insured patients only.
For full eligibility requirements/terms and conditions, please see Savings tab above.
*Maximum benefits apply. For eligible commercially insured patients only. For full eligibility requirements/terms and conditions, please see Savings tab above.
Get your patients started on WELLBUTRIN XL in the office
with free samples.
You are solely responsible for your interactions with that website.
WELLBUTRIN XL® (bupropion hydrochloride extended-release tablets) is indicated for the treatment of major depressive disorder (MDD), and for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (SAD). Periodically reevaluate long-term usefulness for the individual patient.
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS
SUICIDALITY AND ANTIDEPRESSANT DRUGS:
Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term trials. These trials did not show an increase in the risk of suicidal thoughts and behavior with antidepressants use in subjects aged 65 and older.
In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber.
To report SUSPECTED ADVERSE REACTIONS, contact Bausch Health Companies Inc. at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Click here for full Prescribing Information including Boxed Warning regarding suicidal thoughts and behaviors.